(Q37216925)

19 August 2017

1 reference

title

Tactics and technologies to manage nonadherence in patients with schizophrenia (English)

1 reference

19 August 2017

0 references

William M Glazer

1

1 reference

19 August 2017

Mathew J Byerly

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

Current Psychiatry Reports

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

359-369

1 reference

Cost of relapse in schizophrenia

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Use of antipsychotic and antidepressant drugs by chronically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Agreement between seriously mentally ill veterans and their clinicians about medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

A comparative study of clinical events as triggers for psychiatric readmission of multiple recidivists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

'Adherence' and the Negotiated Approach to Patienthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

The clinical application of the biopsychosocial model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Treating substance abuse among patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Compliance therapy in psychotic patients: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Compliance with depot antipsychotic medication by patients attending outpatient clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-008-0057-7

Interventions to improve medication adherence in schizophrenia

21 January 2018

1 reference

12 December 2020

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

1 reference

12 December 2020

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

1 reference

12 December 2020

Review of treatments that can ameliorate nonadherence in patients with schizophrenia

1 reference

12 December 2020

Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.

1 reference

12 December 2020

Substance abuse and the management of medication nonadherence in schizophrenia

1 reference

12 December 2020

Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study

1 reference

12 December 2020

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission

1 reference

12 December 2020

Clinical interventions for treatment non-adherence in psychosis: meta-analysis

1 reference

12 December 2020

Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia

1 reference

12 December 2020

A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications

1 reference

12 December 2020

Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight

1 reference

12 December 2020

Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics

1 reference

12 December 2020

Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study

1 reference

12 December 2020

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

1 reference

12 December 2020

A general method of compliance assessment using centralized pharmacy records. Description and validation

1 reference

12 December 2020

The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia

1 reference

12 December 2020

Financial incentives for antipsychotic depot medication: ethical issues

1 reference

12 December 2020

Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.

1 reference

12 December 2020

Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol

1 reference

12 December 2020

A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.

1 reference

12 December 2020

Teaching medication compliance to psychiatric residents: placing an orphan topic into a training curriculum

1 reference

12 December 2020

Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population.

1 reference

12 December 2020

Relationships among subjective and objective measures of adherence to oral antipsychotic medications

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Antipsychotic medication adherence: is there a difference between typical and atypical agents?

1 reference

12 December 2020

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia

1 reference

12 December 2020

Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors.

1 reference

12 December 2020

Antipsychotic medication adherence in schizophrenia

1 reference

12 December 2020

Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States

1 reference

12 December 2020

Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain

1 reference

12 December 2020

Randomised controlled trial of compliance therapy. 18-month follow-up

1 reference

12 December 2020

Compliance therapy for schizophrenia

1 reference

12 December 2020

Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode

1 reference

12 December 2020

Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics

1 reference

12 December 2020

Medication compliance among the seriously mentally ill in a public mental health system

1 reference

12 December 2020

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia

1 reference

12 December 2020

Compliance therapy: a randomised controlled trial in schizophrenia

1 reference

12 December 2020

Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis

1 reference

12 December 2020

ITAREPS: Information Technology Aided Relapse Prevention Programme in Schizophrenia

1 reference

12 December 2020

Partial compliance and patient consequences in schizophrenia: our patients can do better.

1 reference

12 December 2020

Adherence to conventional and atypical antipsychotics after hospital discharge.

1 reference

12 December 2020

Defining and assessing adherence to oral antipsychotics: a review of the literature

1 reference

12 December 2020

Treating prodromal episodes to prevent relapse in schizophrenia

1 reference

12 December 2020

Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.

1 reference

12 December 2020

Improving medication compliance of a patient with schizophrenia through collaborative behavioral therapy.

1 reference

12 December 2020

Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

1 reference

12 December 2020

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial

1 reference

12 December 2020

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

1 reference

12 December 2020

Interventions to improve antipsychotic medication adherence: review of recent literature

1 reference

12 December 2020

Recovery-oriented psychopharmacology: redefining the goals of antipsychotic treatment

1 reference

12 December 2020

From noncompliance to collaboration in the treatment of schizophrenia

1 reference

12 December 2020

Who receives long-acting antipsychotic medications?

1 reference

12 December 2020

A two-year prospective study of treatment compliance in patients with schizophrenia

1 reference

12 December 2020

Facilitating compliance with antipsychotic medication

1 reference

12 December 2020

Depot neuroleptic therapy: an underutilized treatment option

1 reference

12 December 2020

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

1 reference

12 December 2020

Predicting medication noncompliance after hospital discharge among patients with schizophrenia

1 reference

12 December 2020

A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia.

1 reference

12 December 2020

A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder

1 reference

12 December 2020

Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program

1 reference

12 December 2020

Use of environmental supports among patients with schizophrenia.

1 reference

12 December 2020

Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia

1 reference

12 December 2020

What are "best practices?" Understanding the concept

1 reference

12 December 2020

From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication

1 reference

12 December 2020

Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia

1 reference

12 December 2020

Real-world antipsychotic treatment practices

1 reference

12 December 2020

Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence

1 reference

12 December 2020

The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia

1 reference

12 December 2020

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

1 reference

12 December 2020

Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial.

1 reference

12 December 2020

Adherence to antipsychotic medications.

1 reference

12 December 2020

10.1007/S11920-008-0057-7

Identifiers

DOI

1 reference

release_s23l33alqbailmjw7roab6bhcy

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s23l33alqbailmjw7roab6bhcy

24 November 2022

mapped directly with Wikidata item

1 reference